COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021

Since vaccination against coronavirus disease 2019 (COVID-19) became available, risks related to vaccinating patients with multiple sclerosis (MS) need to be carefully assessed. Characterize safety and occurrence of immediate relapses following COVID-19 vaccination in a large cohort of MS patients....

Full description

Bibliographic Details

Published in:	Multiple sclerosis Vol. 27; no. 6; p. 864
Main Authors:	Achiron, Anat, Dolev, Mark, Menascu, Shay, Zohar, Daniela-Noa, Dreyer-Alster, Sapir, Miron, Shmuel, Shirbint, Emanuel, Magalashvili, David, Flechter, Shlomo, Givon, Uri, Guber, Diana, Stern, Yael, Polliack, Michael, Falb, Rina, Gurevich, Michael
Format:	Journal Article
Language:	English
Published:	England 01.05.2021
Subjects:	COVID-19 Multiple sclerosis adverse events acute relapse immune response vaccination
ISSN:	1477-0970, 1477-0970
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!